(Total Views: 442)
Posted On: 11/18/2019 7:02:09 AM
Post# of 155566
" Independent research study on clinical isolates from patients with documented 4-class drug resistance demonstrated that Leronlimab may play a key role in patients with very limited therapeutic options "
State Dr N Pourhassan
" This is further support for our belief that Leronlimab is positioned to change the treatment paradigm in HIV therapy."
Dr N. Pourhassan concluded.
I be very interested to see results of patients with MDR-4 , those are very sick patients.
But most probably we will not learn any details before presentation.
When Leronlimab will be approved for treatment , there will be no reason for patient with R5 strain virus , ever go above MDR2 , or MDR1 if indication will be improve...
State Dr N Pourhassan
" This is further support for our belief that Leronlimab is positioned to change the treatment paradigm in HIV therapy."
Dr N. Pourhassan concluded.
I be very interested to see results of patients with MDR-4 , those are very sick patients.
But most probably we will not learn any details before presentation.
When Leronlimab will be approved for treatment , there will be no reason for patient with R5 strain virus , ever go above MDR2 , or MDR1 if indication will be improve...
(0)
(0)
